Similarly, the expression of anti-apoptotic factor BCL-2 was significantly higher in the LNM cell line compared to primary stage melanoma MelJuSo (~26 times higher), although it registered a significant decrease in VMM1 (p < 0.0001) (Figure 1A). Here, BCL2 is linked to melanoma.